Legislative Research: US HB19 | 2019-2020 | 116th Congress
Other Sessions
Session | Title/Description | Last Action |
---|---|---|
2021-2022 117th Congress (Introduced - Dead) | To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes. [HB19 2021 Detail][HB19 2021 Text][HB19 2021 Comments] | 2021-10-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
2019-2020 116th Congress (Introduced - Dead) | Establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing un... [HB19 2019 Detail][HB19 2019 Text][HB19 2019 Comments] | 2019-12-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
2017-2018 115th Congress (Introduced - Dead) | Smithsonian Women's History Museum Act This bill establishes a comprehensive women's history museum within the Smithsonian Institution in Washington, DC, to provide for: (1) the collection, study, and establishment of programs related to women's cont... [HB19 2017 Detail][HB19 2017 Text][HB19 2017 Comments] | 2017-04-07 Referred to the Subcommittee on Federal Lands. |
2015-2016 114th Congress (Introduced - Dead) | Reserved for the Minority Leader. [HB19 2015 Detail][HB19 2015 Text][HB19 2015 Comments] | 2015-01-06 Introduced in House |
2013-2014 113th Congress (N/A - Dead) | Reserved for the Minority Leader. [HB19 2013 Detail][HB19 2013 Text][HB19 2013 Comments] | |
2009-2010 111th Congress (Introduced - Dead) | Renames the basic employment eligibility verification pilot program established under the Illegal Immigration Reform and Immigrant Responsibility Act of 1996 as the Employment Eligibility Verification System. Directs the Secretary of Homeland Securi... [HB19 2009 Detail][HB19 2009 Text][HB19 2009 Comments] | 2009-03-06 Referred to the Subcommittee on Workforce Protections. |
References Online
Legislative Citation
APA
US HB19 | 2019-2020 | 116th Congress. (2019, December 19). LegiScan. Retrieved April 19, 2024, from https://legiscan.com/US/bill/HB19/2019
MLA
"US HB19 | 2019-2020 | 116th Congress." LegiScan. LegiScan LLC, 19 Dec. 2019. Web. 19 Apr. 2024. <https://legiscan.com/US/bill/HB19/2019>.
Chicago
"US HB19 | 2019-2020 | 116th Congress." December 19, 2019 LegiScan. Accessed April 19, 2024. https://legiscan.com/US/bill/HB19/2019.
Turabian
LegiScan. US HB19 | 2019-2020 | 116th Congress. 19 December 2019. https://legiscan.com/US/bill/HB19/2019 (accessed April 19, 2024).
Subjects
Administrative law and regulatory procedures
Administrative remedies
Advisory bodies
Appropriations
Biological and life sciences
Business records
Cancer
Chemistry
Child health
Civil actions and liability
Competition and antitrust
Congressional oversight
Consumer affairs
Corporate finance and management
Cosmetics and personal care
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Executive agency funding and structure
Federal Trade Commission (FTC)
Food and Drug Administration (FDA)
Fraud offenses and financial crimes
Genetics
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health information and medical records
Health personnel
Health programs administration and funding
Health technology, devices, supplies
Home and outpatient care
Hospital care
Immunology and vaccination
Income tax deductions
Income tax exclusion
Inflation and prices
Intellectual property
Intergovernmental relations
Judicial review and appeals
Licensing and registrations
Manufacturing
Marketing and advertising
Medicaid
Medical education
Medical research
Medical tests and diagnostic methods
Medicare
Office of the U.S. Trade Representative
Prescription drugs
Product development and innovation
Public participation and lobbying
Research and development
Retail and wholesale trades
State and local government operations
Trade agreements and negotiations
User charges and fees
Women's health
Administrative remedies
Advisory bodies
Appropriations
Biological and life sciences
Business records
Cancer
Chemistry
Child health
Civil actions and liability
Competition and antitrust
Congressional oversight
Consumer affairs
Corporate finance and management
Cosmetics and personal care
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Executive agency funding and structure
Federal Trade Commission (FTC)
Food and Drug Administration (FDA)
Fraud offenses and financial crimes
Genetics
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health information and medical records
Health personnel
Health programs administration and funding
Health technology, devices, supplies
Home and outpatient care
Hospital care
Immunology and vaccination
Income tax deductions
Income tax exclusion
Inflation and prices
Intellectual property
Intergovernmental relations
Judicial review and appeals
Licensing and registrations
Manufacturing
Marketing and advertising
Medicaid
Medical education
Medical research
Medical tests and diagnostic methods
Medicare
Office of the U.S. Trade Representative
Prescription drugs
Product development and innovation
Public participation and lobbying
Research and development
Retail and wholesale trades
State and local government operations
Trade agreements and negotiations
User charges and fees
Women's health
Same As/Similar To
Bill | Relationship | Date | Title | Last Action |
---|---|---|---|---|
HB938 | Related | 2019-05-02 | BLOCKING Act of 2019 Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 | Placed on the Union Calendar, Calendar No. 24. |
HB965 | Related | 2019-05-16 | CREATES Act of 2019 Creating and Restoring Equal Access to Equivalent Samples Act of 2019 | Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III. |
HB1264 | Related | 2019-02-15 | Payment Commission Data Act of 2019 | Referred to the Subcommittee on Health. |
HB1499 | Related | 2019-05-10 | Protecting Consumer Access to Generic Drugs Act of 2019 | Placed on the Union Calendar, Calendar No. 30. |
HB1503 | Related | 2021-01-05 | Orange Book Transparency Act of 2019 | Became Public Law No: 116-290. |
HB1520 | Related | 2020-12-22 | Purple Book Continuity Act of 2019 | Became Public Law No: 116-246. (TXT | PDF) |
HB1781 | Related | 2019-10-29 | Payment Commission Data Act of 2019 | Received in the Senate and Read twice and referred to the Committee on Finance. |
HB1922 | Related | 2020-12-18 | Restoring Access to Medication Act of 2019 | Placed on the Union Calendar, Calendar No. 559. |
HB2087 | Related | 2019-05-21 | Drug Price Transparency Act | Subcommittee Hearings Held. |
HB2115 | Related | 2019-10-29 | Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act | Received in the Senate and Read twice and referred to the Committee on Finance. |
HB2296 | Related | 2019-09-24 | More Efficient Tools to Realize Information for Consumers Act | Placed on the Union Calendar, Calendar No. 170. |
HB2376 | Related | 2019-05-21 | Prescription Pricing for the People Act of 2019 | Subcommittee Hearings Held. |
HB3029 | Related | 2019-06-04 | Improving Low-Income Access to Prescription Drugs Act of 2019 | Subcommittee Hearings Held. |
HB3408 | Related | 2019-06-24 | Shop Rx Act of 2019 | Referred to the Subcommittee on Health. |
HB3415 | Related | 2019-06-24 | Real-Time Beneficiary Drug Cost Bill | Referred to the Subcommittee on Health. |
HB3443 | Related | 2019-07-24 | Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 | Sponsor introductory remarks on measure. (CR E971) |
HB5281 | Related | 2019-12-04 | Drug Price Transparency in Medicaid Act of 2019 | Referred to the Subcommittee on Health. |
SB801 | Related | 2019-03-14 | A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. | Read twice and referred to the Committee on Finance. |
SB1227 | Related | 2019-06-28 | Prescription Pricing for the People Act of 2019 | Placed on Senate Legislative Calendar under General Orders. Calendar No. 131. |
SB1636 | Related | 2020-12-15 | Ensuring Innovation Act | Held at the desk. |
SB1999 | Related | 2019-06-27 | Improving Low Income Access to Prescription Drugs Act of 2019 | Read twice and referred to the Committee on Finance. |
SB2051 | Related | 2019-06-28 | Strengthening Average Sales Price Reporting Act of 2019 | Read twice and referred to the Committee on Finance. |
SB2740 | Related | 2019-12-14 | Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 | Referred to the Subcommittee on Health. |
SB3013 | Related | 2019-12-10 | Encouraging Innovative Benefit Design to Lower Costs for Seniors Act | Read twice and referred to the Committee on Finance. |
HB5444 | Related | 2019-12-18 | Lower Insulin Costs Now Act | Referred to the Subcommittee on Health. |
HB5882 | Related | 2020-02-12 | To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes. | Referred to the House Committee on Energy and Commerce. |
HB6155 | Related | 2020-03-09 | To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes. | Referred to the House Committee on Energy and Commerce. |
HB4400 | Related | 2019-09-20 | Advancing Education on Biosimilars Act of 2019 | Referred to the Subcommittee on Health. |
HB2700 | Related | 2019-06-26 | Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act | Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
SB3942 | Related | 2020-06-11 | Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act | Read twice and referred to the Committee on Finance. |
HB7877 | Related | 2020-07-30 | Lowering Drug Costs for Seniors Act of 2020 | Referred to the Subcommittee on Health. |
HB7898 | Related | 2021-01-05 | To amend title XXX of the Public Health Services Act to provide for a technical correction to provide the Inspector General of the Department of Health and Human Service certain authorities with respect to investigations of information blocking, and for other purposes. | Became Public Law No: 116-321. |
SB3129 | Related | 2019-12-19 | Lower Costs, More Cures Act of 2019 | Read twice and referred to the Committee on Finance. |
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/19/all-info |
Text | https://www.congress.gov/116/bills/hr19/BILLS-116hr19ih.pdf |